Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease

Overview of attention for article published in Frontiers in Pharmacology, June 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,240 followers.

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease #lymphoma #lymsm https://t.co/mk0udMqu0b

New Research: Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease https://t.co/ESiRsqKZOG #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.